Figure 1.
Figure 1. TLR agonists and M-CSF induce CD14+ HLA-DR+ human monocytes to differentiate into macrophages. Monocytes from healthy volunteers were stimulated in vitro with optimized concentrations of M-CSF (500 ng/mL), PAM3 (1 µg/mL), IFN-γ (500 ng/mL), LPS (1 µg/mL), MPLA (1 µg/mL), R848 (3 µg/mL), PGN (1 µg/mL), or FSL-1 (10 ng/mL). Samples stimulated for 3 (n = 2) or 5 (n = 4) days yielded similar patterns of macrophage polarization. (A) Representative dot plots exemplifying changes in 25F9 and CD206 expression. (B) Fold change in the number of MACsuppress (solid bars) or MACinflam (cross-hatched bars) present at the end of culture (mean ± standard deviation of 5-6 independently studied donors per data point). (C) Ratio of CD206+ to CD206− 25F9+ macrophages in the samples described in panel B. *P < .05, **P < .01, ***P < .001 vs unstimulated cultures. Rx, treatment.

TLR agonists and M-CSF induce CD14+HLA-DR+human monocytes to differentiate into macrophages. Monocytes from healthy volunteers were stimulated in vitro with optimized concentrations of M-CSF (500 ng/mL), PAM3 (1 µg/mL), IFN-γ (500 ng/mL), LPS (1 µg/mL), MPLA (1 µg/mL), R848 (3 µg/mL), PGN (1 µg/mL), or FSL-1 (10 ng/mL). Samples stimulated for 3 (n = 2) or 5 (n = 4) days yielded similar patterns of macrophage polarization. (A) Representative dot plots exemplifying changes in 25F9 and CD206 expression. (B) Fold change in the number of MACsuppress (solid bars) or MACinflam (cross-hatched bars) present at the end of culture (mean ± standard deviation of 5-6 independently studied donors per data point). (C) Ratio of CD206+ to CD206 25F9+ macrophages in the samples described in panel B. *P < .05, **P < .01, ***P < .001 vs unstimulated cultures. Rx, treatment.

Close Modal

or Create an Account

Close Modal
Close Modal